Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Turlure · SciRah

Researcher profile · Semantic Scholar

P. Turlure

Share profile

P. Turlure — researcher profile on SciRah

h-index: 41
Works: 273
Citations: 7,953

Most-cited papers

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
J. Lambert, C. Pautas, C. Terré, E. Raffoux +13 more
2018Haematologica157 citations Open access
Semantic Scholar
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients
F. Nicolini, S. Dulucq, L. Boureau, P. Cony-Makhoul +29 more
2019Clinical Cancer Research103 citations
Semantic Scholar
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia patients treated in the ALFA0701 trial.
É. Fournier, Nicolas Duployez, B. Ducourneau, E. Raffoux +17 more
2019Blood76 citations
Semantic Scholar
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML, an ALFA study.
M. Duchmann, J. Micol, Nicolas Duployez, E. Raffoux +23 more
2021Blood58 citations Open access
Semantic Scholar
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
J. Maertens, T. Lodewyck, J. Donnelly, S. Chantepie +27 more
2022Clinical Infectious Diseases50 citations Open access
Semantic Scholar
Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)
O. Ottmann, H. Pfeifer, J. Cayuela, K. Spiekermann +21 more
2018Blood44 citations Open access
Semantic Scholar
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
L. Fenwarth, X. Thomas, S. de Botton, Nicolas Duployez +33 more
2020Blood43 citations Open access
Semantic Scholar
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification.
D. Bronnimann, D. Garcia-Hermoso, F. Dromer, F. Lanternier +147 more
2020Medical Mycology41 citations Open access
Semantic Scholar
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
P. Chevallier, T. Leguay, Marc Delord, Cyril Šálek +35 more
2024Journal of Clinical Oncology39 citations
Semantic Scholar
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups
M. Robin, R. Porcher, C. Orvain, J. Bay +23 more
2021Bone Marrow Transplantation30 citations Open access
Semantic Scholar
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
W. Wiktor-Jedrzejczak, J. Drozd-Sokołowska, D. J. Eikema, J. Hoek +28 more
2019Bone Marrow Transplantation29 citations Open access
Semantic Scholar
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Y. Chalandon, P. Rousselot, Sylvie Chevret, J. Cayuela +26 more
2024Blood28 citations Open access
Semantic Scholar
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO
P. Dumas, E. Raffoux, Emilie Bérard, S. Bertoli +38 more
2022Leukemia27 citations Open access
Semantic Scholar
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
P. Prata, M. Resche-Rigon, D. Blaise, G. Socié +15 more
2019Biology of Blood and Marrow Transplantation24 citations Open access
Semantic Scholar
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
P. Peterlin, Y. Le Bris, P. Turlure, P. Chevallier +18 more
2023The Lancet Haematology23 citations
Semantic Scholar
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial
S. Dulucq, F. Nicolini, D. Réa, P. Cony-Makhoul +26 more
2022Haematologica20 citations Open access
Semantic Scholar
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
O. Penack, C. Peczynski, S. M. van der Werf, J. Finke +20 more
2020Frontiers in Immunology20 citations Open access
Semantic Scholar
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
Claire Michel, M. Robin, S. Morisset, D. Blaise +32 more
2023Bone Marrow Transplantation19 citations Open access
Semantic Scholar
CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM
P. Peterlin, P. Turlure, P. Chevallier, M. Gourin +15 more
2021Blood17 citations Open access
Semantic Scholar
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.
N. Boissel, Sylvie Chevret, Françoise Rigal-Huguet, T. Leguay +33 more
2025Blood16 citations Open access
Semantic Scholar
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
O. Tournilhac, B. Altmann, B. Friedrichs, K. Bouabdallah +38 more
2024Journal of Clinical Oncology16 citations
Semantic Scholar
Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
S. Belaiche, B. Décaudin, A. Caron, Nicolas Depas +28 more
2020Fundamental & Clinical Pharmacology16 citations
Semantic Scholar
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
C. Lacan, Jérôme Lambert, E. Forcade, M. Robin +35 more
2024Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program.
D. Beauvais, C. Robin, A. Thiébaut, S. Alain +15 more
2022Journal of Clinical Virology15 citations Open access
Semantic Scholar
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia
C. Pautas, E. Raffoux, J. Lambert, O. Legrand +10 more
2021Bone Marrow Transplantation14 citations Open access
Semantic Scholar
Treatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial
F. Nicolini, G. Étienne, F. Huguet, A. Guerci-Bresler +25 more
2021Blood14 citations
Semantic Scholar
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use
Auriane Lesieur, X. Thomas, O. Nibourel, N. Boissel +16 more
2020Haematologica14 citations Open access
Semantic Scholar
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC
A. Le Bourgeois, M. Labopin, A. Marçais, R. de Latour +17 more
2020Annals of Hematology14 citations
Semantic Scholar
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
M. Hunault, C. Pautas, S. Bertoli, P. Dumas +34 more
2025NEJM Evidence13 citations
Semantic Scholar
Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients
M. Labriffe, Julien Vaidié, C. Monchaud, J. Debord +4 more
2020British Journal of Clinical Pharmacology13 citations Open access
Semantic Scholar
Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Christine Robin, Catherine Cordonnier, G. Tridello, N. Knelange +26 more
2023Transplantation and Cellular Therapy12 citations Open access
Semantic Scholar
Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study
D. Greenfield, N. Salooja, C. Peczynski, S. M. van der Werf +20 more
2021Bone Marrow Transplantation12 citations Open access
Semantic Scholar
The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.
F. Nicolini, G. Étienne, F. Huguet, A. Guerci-Bresler +28 more
2019Blood12 citations Open access
Semantic Scholar
Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial.
S. Chantepie, J. Mear, A. Briant, JP Vilque +16 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis11 citations
Semantic Scholar
In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial
N. Boissel, F. Huguet, T. Leguay, H. Mathilde +31 more
2022Blood11 citations Open access
Semantic Scholar
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML
M. Duchmann, O. Wagner-Ballon, T. Boyer, M. Cheok +21 more
2021Leukemia11 citations
Semantic Scholar
Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT
L. K. Gjærde, C. Eeltink, J. Stringer, J. Mooyaart +14 more
2022Bone Marrow Transplantation9 citations
Semantic Scholar
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial
O. Tournilhac, M. Le Garff-Tavernier, S. N. Quoc, E. Forcade +21 more
2020Haematologica9 citations Open access
Semantic Scholar
The Omission of High-Dose Cytarabine during Consolidation Therapy of Ph-Positive ALL Patients Treated with Nilotinib and Low-Intensity Chemotherapy Results in an Increased Risk of Relapses Despite Non-Inferior Levels of Late BCR-ABL1 MRD Response. First Results of the Randomized Graaph-2014 Study
P. Rousselot, Y. Chalandon, S. Chevret, J. Cayuela +22 more
2021Blood8 citations
Semantic Scholar
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
A. Bouvier, J. Hamel, J. Delaunay, É. Delabesse +36 more
2021European Journal of Haematology8 citations
Semantic Scholar
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party
O. Penack, C. Peczynski, S. M. van der Werf, J. Finke +20 more
2019Haematologica8 citations Open access
Semantic Scholar
Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study
N. Boissel, C. Graux, Françoise Huguet, Florence Pasquier +29 more
2023Blood7 citations Open access
Semantic Scholar
Prognostic Significance of Concurrent Gene Mutations in Intensively Treated Patients with IDH1/2 Mutated AML
M. Duchmann, J. Micol, Nicolas Duployez, E. Raffoux +23 more
2019Blood7 citations Open access
Semantic Scholar
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
E. Kaphan, F. Bettega, Nicolas Vallet, N. Fégueux +24 more
2024Haematologica6 citations Open access
Semantic Scholar
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
M. Srour, Tamim Alsuliman, J. Labreuche, C. Bulabois +10 more
2023Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT
M. Nabergoj, K. Mauff, D. Beelen, A. Ganser +22 more
2020Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.
Nicolas Duployez, Romane Joudinaud, A. Boudry, M. Hunault +41 more
2026Blood5 citations Open access
Semantic Scholar
Prognostic Impact of Monoallelic Versus Biallelic TP53 Alterations in Intensively-Treated Adults AML Patients: A Retrospective Study from the ALFA Group
L. Fenwarth, Loic Vasseur, Nicolas Duployez, C. Gardin +14 more
2022Blood5 citations
Semantic Scholar
Replacing the Anthracycline By Gemtuzumab Ozogamicin in Older Patients with De Novo Standard-Risk Acute Myeloid Leukemia Treated Intensively - Results of the Randomized ALFA1401-Mylofrance 4 Study
J. Lambert, J. Lambert, Emilie Lemasle, M. Joris +22 more
2021Blood5 citations Open access
Semantic Scholar
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
A. Campidelli, M. Robin, T. Rémen, A. Luc +14 more
2021Clinical Lymphoma, Myeloma & Leukemia5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Chantepie×18
Invite
S. Chantepie — researcher profile on SciRah
H. Dombret×16
Invite
H. Dombret — researcher profile on SciRah
E. Raffoux×14
Invite
E. Raffoux — researcher profile on SciRah
C. Pautas×13
Invite
C. Pautas — researcher profile on SciRah

×12

Invite

J. Lambert — researcher profile on SciRah

C. Preudhomme×11

Invite

C. Preudhomme — researcher profile on SciRah

Invite

C. Gardin — researcher profile on SciRah

M. Escoffre-barbe×10

Invite

M. Escoffre-barbe — researcher profile on SciRah

Invite

X. Thomas — researcher profile on SciRah

Emilie Lemasle×10

Invite

Emilie Lemasle — researcher profile on SciRah

P. Chevallier×10

Invite

P. Chevallier — researcher profile on SciRah

Invite

D. Caillot — researcher profile on SciRah